A novel conjugate as a major metabolite of bromperidol in man
- 1 May 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 34 (5) , 299-303
- https://doi.org/10.1111/j.2042-7158.1982.tb04711.x
Abstract
The major urine metabolites of the neuroleptic drug, bromperidol, after oral doses to rats and dogs are p-fluorophenylacetic acid and its glycine conjugate resulting from oxidative N-dealkylation. While the same metabolites were also detected in human urine, also present was a major unknown component representing 50% of the total urine metabolites, which apparently was not formed by rats and dogs to any extent. Mass spectroscopic investigations of the metabolite showed that it could be thermally degraded to bromperidol and contained a substituent attached to the tertiary hydroxyl group. The mass spectrum of the metabolite after trifluoroacetylation was consistent with an O-glucofuranosiduronolactone conjugate of bromperidol.This publication has 6 references indexed in Scilit:
- Glucuronic acid conjugates of clofibrate: Four isomeric structuresLife Sciences, 1981
- Radioimmunoassay of bromperidol and haloperidol in human and canine plasmaEuropean Journal of Drug Metabolism and Pharmacokinetics, 1980
- Bilirubin conjugates of human bile. The excretion of bilirubin as the acyl glycosides of aldobiouronic acid, pseudoaldobiouronic acid and hexuronosylhexuronic acid, with a branched-chain hexuronic acid as one of the components of hexuronosylhexuronideBiochemical Journal, 1970
- Distribution, excretion and metabolism of neuroleptics of the butyrophenone type: Part I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar ratEuropean Journal of Pharmacology, 1967
- Metabolism of Drugs. XLVI. Behavior of 2-Naphthyl β-D-Glucofuranosiduronic Acid toward β-Glucuronidase.CHEMICAL & PHARMACEUTICAL BULLETIN, 1964
- Metabolism of Drugs. XLV. Synthesis of 2-Naphthyl β-D-Glucofuranosiduronic Acid.CHEMICAL & PHARMACEUTICAL BULLETIN, 1964